Geng J, Wang L, Qu M, Song Y, Lin X, Chen Y, et al
13 In 1993, The Journal of Clinical Apheresis published a paper detailing the use of TPE as either a first- or second-line therapy to be used with other modalities on disorders such as Raynauds disease, systemic lupus erythematosus, coagulation factor inhibitors, familial hypercholesterolemia, acute Guillain-Barr syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, cryoglobulinemia, Goodpastures syndrome, and thrombotic thrombocytopenic purpura
Vegans and vegetarians are particularly at risk for B12 deficiency because plant-based foods do not naturally contain vitamin B12
Users often combine peptide therapy with targeted exercises that create more space in the shoulder joint
Investors can spread their money across multiple properties, minimizing the impact of any individual propertys performance, by pooling their funds
Phase 2b human trial data available (obesity)